Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study

K Andersen1, L J Launer, A Ott

  • 1Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.

Neurology
|August 1, 1995
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association of arterial stiffness and arterial calcification: the Rotterdam study.

Journal of human hypertension·2008
Same author

Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study.

Journal of neurology, neurosurgery, and psychiatry·2007
Same author

Explaining differences in birthweight between ethnic populations. The Generation R Study.

BJOG : an international journal of obstetrics and gynaecology·2007
Same author

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

European journal of epidemiology·2007
Same author

Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.

Neurology·2007
Same author

Fetal kidney volume and its association with growth and blood flow in fetal life: The Generation R Study.

Kidney international·2007

Nonsteroidal anti-inflammatory drugs (NSAIDs) may lower the risk of developing Alzheimer's disease (AD). This study found a reduced relative risk for AD in NSAID users compared to non-users.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epidemiology

Background:

  • Emerging evidence suggests nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce Alzheimer's disease (AD) risk.
  • Understanding this potential link is crucial for neurodegenerative disease prevention strategies.

Purpose of the Study:

  • To investigate the association between NSAID use and the risk of Alzheimer's disease (AD).
  • To explore the potential protective effects of NSAIDs against AD in an older population.

Main Methods:

  • Cross-sectional, population-based study involving older adults.
  • Comparison of AD risk between NSAID users and non-users, controlling for demographic and medication variables.
  • Secondary analysis using topical medication users as a control group to mitigate confounding by indication.

Related Experiment Videos

Main Results:

  • A reduced relative risk (RR) of 0.38 for AD was observed in NSAID users versus non-users (95% CI: 0.15–0.95).
  • Adjusted RR for AD was 0.54 (95% CI: 0.16–1.78) when comparing NSAID users to non-users on topical medications.

Conclusions:

  • Findings suggest a potential protective association between NSAID use and reduced Alzheimer's disease risk.
  • Further research is warranted to confirm these results and elucidate the underlying mechanisms.